Whilst HIF-1α expression has been consistently associated with disease progression and worse prognosis in breast cancer [10, 20, 61–63], the prognostic implications of HIF-2α expression have remained unclear [64, 65]. The gene discussed is EPAS1; the disease is breast cancer.